Corrigendum: Decreased risk of anxiety in Diabetic patients receiving Glucagon-Like Peptide-1 receptor agonist: a Nationwide, Population-based Cohort Study
Some studies (like a recent one tracking over 18,000 adults)suggest that tirzepatide (used in Mounjaro and Zepbound), may lead to slightly more weight loss on average than semaglutide (in Wegovy, Ozempic, and Rybelsus)
Powered by plants that perform, not synthetic pharmaceuticals
Gelatin retains peptides that inhibit DPP-IV and stimulate GLP-1 more effectively than collagen
That said, it's still not a nutritional home run
Values and Preferences The kidney and cardiovascular benefits of additional therapy with RAASi, SGLT2i, GLP1-RA, and nsMRA, including additional testing and visits, must be balanced against the need for additional medications, as well as associated lab testing for individuals with residual risk due to persistent nephropathy with A3 albuminuria